Hypertension in 2017-what is the right target?

JAMA - Journal of the American Medical Association

Volumn 317, Issue 6, 2017, Pages 579-580

  Chobanian, Aram V ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CANDESARTAN HEXETIL PLUS HYDROCHLOROTHIAZIDE; ROSUVASTATIN; HYPOCHOLESTEROLEMIC AGENT;

AGE; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL RESEARCH; COMORBIDITY; CONSENSUS; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; LIFESTYLE; MEDICAL DECISION MAKING; MEDICAL HISTORY; MEDICAL SOCIETY; MORTALITY; NOTE; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; MIDDLE AGED; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERENCE VALUES;

EID: 85014589095     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.0105     Document Type: Note

References (9)

1. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003; 289(19):2560-2572.
2. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults. JAMA. 2014;311(5): 507-520.
3. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens. 2013;31(7):1281-1357.
4. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community. J Hypertens. 2014; 32(1):3-15.
5. CushmanWC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-1585.
6. Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive vs standard blood-pressure control. N Engl J Med. 2015;373(22): 2103-2116.
7. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged-75 years. JAMA. 2016;315(24):2673-2682.
8. Yusuf S, Lonn E, Pais P, et al. Blood-pressure and cholesterol lowering in persons without cardiovascular disease. N Engl J Med. 2016;374(21): 2032-2043.
9. Chobanian AV. SPRINT results in older patients. JAMA. 2016;315(24):2669-2670.